Lung Cancer, An Issue of Hematology/Oncology Clinics, 1st Edition
著者 :
By Roy S. Herbst, MD, PhD and Daniel Morgensztern, MD
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemothera
...view more
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!
著者情報
By Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine, USA and Daniel Morgensztern, MD, Washington University School of Medicine
By Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine, USA and Daniel Morgensztern, MD, Washington University School of Medicine
https://shop.elsevier.jp/lung-cancer-an-issue-of-hematologyoncology-clinics-9780323496605.html302294Lung Cancer, An Issue of Hematology/Oncology Clinicshttps://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323496605.jpg1390313903JPYInStock/Medicine & Surgery/Hematology/eBooks/Medicine/Hematology/eBooks/eBooks/Medicine/Hematology/Medicine/Hematology/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book443121443887245054622505466552550405259911580357859368005936822593682759368321418269243350884886536505455351451205259833579989258035265936799593680959368235936828This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more! This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!00add-to-cart97803234966052016専門医By Roy S. Herbst, MD, PhD and Daniel Morgensztern, MD20171E-BookElsevier02016/12/03IN STOCKBy <STRONG>Roy S. Herbst</STRONG>, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine, USA and <STRONG>Daniel Morgensztern</STRONG>, MD, Washington University School of MedicineE-BookE-BookThe Clinics: Internal MedicineS013Hematology, Medicine米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください
